A composition and therapeutic kit including an aerosol packaging assembly including a container accommodating a pressurized product and an outlet capable of releasing a foamable composition, including a nonsteroidal immunomodulating agent as a foam. The pressurized product includes a foamable composition including:a) a container accommodating a pressurized product； andb) an outlet capable of releasing the pressurized product as a foam； wherein the pressurized product comprises a foamable composition including: i. a nonsteroidal immunomodulating agent；ii. at least one organic carrier selected from the group consisting of a hydrophobic organic carrier, a polar solvent, an emollient and mixtures thereof, at a concentration of about 2% to about 50% by weight；iii. a surface-active agent；iv. about 0.1% to about 5% by weight of a therapeutically active foam adjuvant, selected from the group consisting of a fatty alcohol, a fatty acid, a hydroxyl fatty acid； and mixtures thereof；v. about 0.01% to about 5% by weight of at least one polymeric additive selected from the group consisting of a bioadhesive agent, a gelling agent, a film forming agent and a phase change agent；vi. water； andvii. liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition.
